Comera Life Sciences Holdings Inc
Change company Symbol lookup
Select an option...
CMRA Comera Life Sciences Holdings Inc
ADI Analog Devices Inc
KEY KeyCorp
FNF Fidelity National Financial Inc
CTAQU Carney Technology Acquisition Corp. II
MUE BlackRock MuniHoldings Quality Fund II, Inc.
NC NACCO Industries Inc
RXT Rackspace Technology Inc
THCHW TH International Equity Warrant Exp 28th Sept 2027 *W EXP 09/28/2027
PFLT PennantPark Floating Rate Capital Ltd
Go

Company profile

Comera Life Sciences Holdings, Inc. is a pre-clinical biotechnology company. The Company is engaged in developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience. Its proprietary formulation platform, SQore, is designed to transform intravenous (IV) biologics into subcutaneous (SQ) versions that patients can self-administer in a single dose. The platform optimizes current versions of subcutaneous biologics and produce biosimilar versions of existing subcutaneous products. It has the potential for broad applications in therapeutic areas dependent on protein-based biologic treatments. The SQore platform includes proprietary structural calculations combined with analytical measurements to guide the selection of excipients for a given protein. The Company’s product programs: CLS-001, a preclinical stage biobetter for Crohn’s and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications.

Price
Delayed
$1.85
Day's Change
-0.08 (-4.15%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.11
Day's Low
1.82
Volume
(Below Average)

Today's volume of 165,672 shares is on pace to be lower than CMRA's 10-day average volume of 337,022 shares.

165,672

Cedar Fair sees record year-to-date revenue through July 4

6:17 am ET July 7, 2022 (MarketWatch)
Print

Cedar Fair L.P. (FUN) said Thursday that year-to-date revenue through July 4 was a record $704 million, up 20% from the comparable period in pre-pandemic 2019 that went through July 8. The stock was still inactive in premarket trading. The increase in revenue was fueled by new highs for in-park per capita spending of $59.52 and growth in out-of-park revenue, such as resort properties, to $88 million. The amusement park operator said those gains were partially offset by a slower recovery in its group-sales channel and a calendar shift resulting in fewer operating days through the July 4 weekend. "Our strong early-season trends indicate that consumer demand remains healthy and that guests are responding well to the quality and breadth of the entertainment experience we offer," said Chief Executive Officer Richard Zimmerman. The stock has slipped 6.8% year to date, while the S&P 500 has dropped 19.3%.

-Tomi Kilgore

	

(END) Dow Jones Newswires

July 07, 2022 06:17 ET (10:17 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.